Juliet Tammenoms Bakker
Juliet Tammenoms Bakker has served as a member of Venus Concept’s board of directors since May 2014. Ms. Tammenoms Bakker is a Founder and Managing Director of Longitude Capital Management where she focuses on investments in medical technology. Prior to joining Longitude, Ms. Tammenoms Bakker was a Managing Director of Pequot Ventures where she founded the life sciences investment practice. Prior to Pequot, she was Director of Strategic Planning and Director of Operations for Waste Management International, Inc. Previously she was a sell-side equity analyst with Banque Paribas. Ms. Tammenoms Bakker began her career as an investment banker in the corporate finance department at PaineWebber, Inc. She currently serves on the boards of Alphaeon Corporation, Axonics Modulation Technologies (NASDAQ:AXNX), DyaMX, Inc., Encore Dermatology, Inc., Nalu, and RxSight, Inc. She has previously served on the boards of Ablation Frontiers LLC (acquired by Medronic plc (NYSE:MDT)), AqueSye (acquired by Allergen plc (NYSE:AGN)) CryoVascular Systems, Inc. (NASDAQ:CSII) (acquired by Boston Scientific Corporation (NYSE:BSX)), Embolic Protection Devices (acquired by Boston Scientific Corporation), Enteric Medical (acquired by Boston Scientific Corporation), Eyeonics Inc. (acquired by Bausch+Lomb), Genyx Medical (acquired by C.R.Bard, Inc.), Insulet (PODD), Precision Dermatology, Inc. (acquired by Bausch Health Companies Inc. (NYSE: BHC) formerly, Valeant Pharmaceuticals), and Sadra Medical Inc. (acquired by Boston Scientific Corporation). Ms. Tammenoms Bakker holds an M.P.A. from the Harvard Kennedy School and a B.Sc. from the College of Agriculture and Life Sciences at Cornell University, or CALS, where she is a member of the CALS Advisory Council. Ms. Tammenoms Bakker is also a board member of the Boys and Girls Club of Greenwich.